Premium Reports
Population Health Data Acquisition & Analysis 2020

Population Health Data Acquisition & Analysis 2020
Turning Data into Actionable Insights

December 15, 2020 | Read Time: 6  minutes

Current Time Inside Cache Tag Helper: 4/11/2021 3:27:11 AM and Model.reportId = 1668

Hoping to consolidate population health management (PHM) solutions, healthcare organizations today are seeking out technology that addresses a wide variety of their PHM needs. Most of the core functionality that organizations are looking for centers around data acquisition and data analysis. This report offers a focused look at the first two pillars of PHM—data acquisition and data analysis—to uncover which solutions do best at compiling accurate, timely data and turning it into actionable insights. This report also includes an overall update on vendor performance in all PHM areas.

Healthcare Providers,
Want to see full details?

Not a Provider, contact us for pricing details.

Current Time Inside Cache Tag Helper: 4/11/2021 3:27:11 AM and Model.reportId = 1668

Key Findings:

  1. Pillars of Population Health Management Technology
  2. Innovaccer Earns Physician Trust Via Strong Data Mapping
  3. Reporting & Dashboards: Flexible, Easy-to-Use Dashboards from Azara Healthcare, SPH Analytics Deliver the Right Data at the Right Time
  4. Prioritized Worklists: Identifying Actionable Insights Requires Manual Effort for customers of Lightbeam, NextGen, Optum
  5. Risk Scoring: Optum's Broad Risk-Model Experience Drives Success with a Variety of VBR Arrangements
  6. Key PHM Market Trends in 2020
 Download Report Brief  Download Full Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.